Marianne Weisskopf

A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA)

Dudley J. Pennell, John B. Porter, Antonio Piga et al. · Blood · 2014 · 120 citations · Full text

Medicine, Hematology, Pharmacology +12

The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg

J Schrader, Antonio Salvetti, C. Calvo et al. · International Journal of Clinical Practice · 2009 · 45 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

A Randomized, Double-Blind, Placebo-Controlled Study to Determine the Effects of Valsartan on Exercise Time in Patients with Symptomatic Heart Failure with Preserved Ejection Fraction

Hari Parthasarathy, Burkert Pieske, Marianne Weisskopf et al. · European Journal of Heart Failure · 2009 · 44 citations · Full text

Medicine, Cardiology, Pharmacology +12

Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24‐week, Randomized, Double‐Blind Parallel‐Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily)

Zhenxin Zhang, Zhen Hong, Yanping Wang et al. · CNS Neuroscience & Therapeutics · 2016 · 18 citations · Full text

Medicine, Neurology, Pharmacotherapy +14

A Multicenter, Randomized, Open-Label Trial Evaluating Deferasirox Compared with Deferoxamine for the Removal of Cardiac Iron in Patients with β-Thalassemia Major and Iron Overload (CORDELIA).

Dudley J. Pennell, John B. Porter, Antonio Piga et al. · Blood · 2012 · 11 citations

Medicine, Hematology, Pharmacology +16